| 4th Vaccines China 2012 When: 9:00 am to 5:00 pm, Tuesday - Wednesday, 24-25 April 2012
Where: Grand Hyatt Shanghai, China
Lecture Title: Forging Successful Collaborations & Ensuring Quality and Compliance Lecture Summary: Vaccines China 2012 is a comprehensive event focused on vaccines development through to manufacturing. Good manufacturing practices and strategies will be reviewed, alongside potential block-buster technologies and R&D projects. Speaker: Dr. Masato Tashiro, MD, Ph.D.Director, Influenza Virus Research Center, National Institute of Infectious Diseases, Japan Prof. Sudhanshu Vrati, PhD, FASc, FNASc, Dean, Translational Health Science and Technology Institute & Head, Vaccine and Infectious Disease Research Centre & Principal Scientist, National Institute of Immunology, India Dr. Pele Chong, Director and Distinguished Investigator, Vaccines Research and Development Center, National Health Research Institute, Taiwan Dr. Aihua Zhang, Professor and Deputy Director of R&D Department, China National Biotec Group(CNBG), China National Pharmaceutical Group Corp.(Sinopharm), China Jin Yulan, President, Changchun Institute of Biological Products, China Dr. Li Shi, Ph.D., CEO, Shanghai Zerun Biotechnology, Wison Group, China Dr. Gao Qiang, Director of R&D, Sinovac Biotech Co. Ltd, China Dr. Bin Wang, Ph.D, Professor, Key Laboratory of Medical Molecular Virology of MOH and MOE, Fudan University Shanghai Medical College, China Dr. Jean-Denis Shu, MD MBA,Medical Director, Sanofi Pasteur, China Dr. Tang Haiwen, MD. Ph. D., Medical Director, GSK Biologicals China/ Hong Kong, China Dr. Bin Wang, Ph.D, Professor, Key Laboratory of Medical Molecular Virology of MOH and MOE, Fudan University Shanghai Medical College, China Giridhar Rao, Manager of Global Regulatory Affairs and Compliance, Indian Immunologicals, India Dr. Alexander Von Gabain, Member of the Supervisory Board and Co-Founder, Intercell AG, Chair of the Governing Board, European Institute of Innovation and Technology & EIT Professor, Max Perutz Laboratories, University of Vienna & Karolinska Institute in Stockholm Dr. Alain Bouckenooghe, MD, MPH, Clinical R&D and Medical Affairs, Associate VP, Regional Head Asia/Pacific, Sanofi Pasteur, Singapore Prof. Nikolai Petrovsky, Director of Endocrinology, Flinders Medical Centre & Research Director, Vaxine Pty Ltd, Australia Dr. Guy de Martynoff, PhD, Managing Director, DMS Biotechnology, Belgium Schedule: 24 April 2012 9:00 – 11:40am: Joint Plenary Session with 7th China Pharma R&D & 3rd Biosimilars Asia 11:40am – 1:00pm: Vaccines Industry Outlook 1:00 - 2:00pm: Networking Lunch 2:00 – 4:00pm: Vaccines Quality Control & Compliance 4:00 – 5:30pm: Novel Development of Vaccines 25 April 2012 9:00 – 10:10am: Novel Vaccine Candidates for Tropical Diseases 10:10 – 11:40am: Research and Clinical Updates for EV71 Vaccines 11:40am – 12:40pm: Innovations and Technological Advancements 12:40 – 2:00pm Networking Lunch 2:00 – 4:00pm Innovations and Technological Advancements 4:00 – 5.10pm Future Opportunities for Sustainable Return on Investment |
